Pro Medicus (OTCMKTS:PMCUF) Shares Gap Up – Here’s What Happened

Posted by Brian Himes on Oct 21st, 2026

Pro Medicus Limited (OTCMKTS:PMCUF – Get Free Report)’s share price gapped up prior to trading on Monday. The stock had previously closed at $105.09, but opened at $116.33. Pro Medicus shares last traded at $116.33, with a volume of 1 shares changing hands.

Wall Street Analysts Forecast Growth

Separately, Jefferies Financial Group cut shares of Pro Medicus from a “buy” rating to a “hold” rating in a research report on Wednesday, July 8th. One investment analyst has rated the stock with a Hold rating. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus price target of $155.00.

Check Out Our Latest Research Report on PMCUF

Pro Medicus Stock Performance

The business’s 50-day moving average price is $120.36 and its two-hundred day moving average price is $113.79.

About Pro Medicus

(Get Free Report)

Pro Medicus Limited is an Australian medical technology company that develops software for medical imaging and healthcare organizations. Its solutions are designed to help hospitals, radiology practices and other providers store, manage, view and distribute medical images and related clinical information.

The company’s principal platform is Visage 7, an enterprise imaging system developed and commercialized through its wholly owned subsidiary, Visage Imaging. The platform supports the review of diagnostic studies such as computed tomography, magnetic resonance imaging and other medical images, with an emphasis on enterprise-wide access, workflow efficiency and advanced visualization.

Founded in 1983 and headquartered in Melbourne, Australia, Pro Medicus serves healthcare customers in Australia, North America and Europe.